12:00 AM
Feb 28, 2000
 |  BC Week In Review  |  Clinical News  |  Regulatory

AP1903 small molecule dimerizer regulatory update

The FDA granted Orphan Drug designation for AP1903 to treat acute graft-versus-host disease (GvHD) as...

Read the full 51 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >